April 24, 2020 / 6:41 AM / a month ago

BRIEF-Scancell Holdings Says Initiated Research Programme To Develop Vaccine For Covid-19

April 24 (Reuters) - Scancell Holdings PLC:

* SCANCELL HOLDINGS - INITIATED A RESEARCH PROGRAMME TO DEVELOP A VACCINE FOR COVID-19

* SCANCELL HOLDINGS - INITIAL RESEARCH IS UNDERWAY AND ANTICIPATES INITIATING A PHASE 1 CLINICAL TRIAL IN Q1 2021, SUBJECT TO FUNDING

* SCANCELL HOLDINGS - ACTIVELY SEEKING DEVELOPMENT PARTNERS AND ADDITIONAL FUNDING TO SUPPORT RAPID DEVELOPMENT OF VACCINE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below